ICU vs FEMY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

ICU

41.0
AI Score
VS
FEMY Wins

FEMY

51.9
AI Score

Investment Advisor Scores

ICU

41score
Recommendation
HOLD

FEMY

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ICU FEMY Winner
Revenue 756,716 1.75M ICU
Net Income -3.62M -11.78M FEMY
Net Margin -478.8% -675.1% FEMY
Operating Income -9.29M -11.97M FEMY
ROE -89.9% -2511.7% FEMY
ROA -29.5% -221.8% FEMY
Total Assets 12.29M 5.31M FEMY
Cash 1.44M 3.99M ICU
Current Ratio 2.14 1.03 FEMY

Relative Price Performance (Last 90 Days)

ICU 1M: -65.1% · 3M: -67.0% FEMY 1M: -10.3% · 3M: -38.9%

Current Technical Phase

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.0%), weak momentum, RSI 23

RSI (14): 22.7 · Price: $1.05

FEMY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.3%), weak momentum, RSI 38

RSI (14): 38.4 · Price: $1.40

Fundamentals Snapshot

Metric ICU FEMY
Market Cap — —
Forward P/E -0.5 -0.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.8% -0.2%
Gross Margin 0.9% 0.6%
Operating Margin -8.2% -7.6%
EPS -2.97 -3.28
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, FEMY is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.